MiniMed (MMED) Net Income towards Common Stockholders (2025 - 2026)
MiniMed (MMED) posted Net Income towards Common Stockholders of -$185.0 million for Q2 2026, down 66.67% on a QoQ basis from -$111.0 million in Q1 2026, and down 9.47% year-over-year from -$204.3 million in Q2 2025.
MiniMed (MMED) Net Income towards Common Stockholders (2025 - 2026) Analysis & Trends
MiniMed's Net Income towards Common Stockholders history runs 2 years deep, the most recent figure standing at -$185.0 million for Q2 2026.
- Quarterly Net Income towards Common Stockholders fell 9.47% year-over-year to -$185.0 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was -$472.0 million (changed N/A YoY) and the FY2026 annual result came in at -$317.0 million, down 59.3% from the prior year.
- Net Income towards Common Stockholders was -$185.0 million for Q2 2026 at MiniMed, down from -$111.0 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at -$7.0 million in Q1 2025 and bottomed at -$185.0 million in Q2 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 32.02 Bn | 24.70 Bn | 662.02 Mn | 260.94 Mn |
| 2 | BrightSpring Health Services | 14.71 Bn | 13.81 Bn | 482.22 Mn | 148.77 Mn |
| 3 | Healthequity | 8.37 Bn | 8.10 Bn | 256.31 Mn | 69.42 Mn |
| 4 | Hinge Health | 5.92 Bn | 5.61 Bn | 154.23 Mn | 34.01 Mn |
| 5 | 10x Genomics | 5.92 Bn | 5.38 Bn | 106.18 Mn | -13.47 Mn |
| 6 | MiniMed | 4.50 Bn | 4.21 Bn | 480.00 Mn | -185.00 Mn |
| 7 | Waystar Holding | 4.42 Bn | 4.36 Bn | 216.84 Mn | 43.28 Mn |
| 8 | Doximity | 3.94 Bn | 3.19 Bn | 125.97 Mn | 19.11 Mn |
| 9 | Privia Health | 3.11 Bn | 2.69 Bn | - | 3.71 Mn |
| 10 | Omnicell | 1.88 Bn | 1.64 Bn | 140.36 Mn | 11.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 24, 2026 | -185.00 Mn |
| Jan 23, 2026 | -111.00 Mn |
| Apr 25, 2025 | -169.00 Mn |
| Jan 24, 2025 | -7.00 Mn |